These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31060735)

  • 1. Evidence in follow-up and prognosis of esophagogastric junction cancer.
    Sanz Álvarez L; Turienzo Santos E; Rodicio Miravalles JL; Moreno Gijón M; Amoza Pais S; Sanz Navarro S; Rizzo Ramos A
    Cir Esp (Engl Ed); 2019 Oct; 97(8):465-469. PubMed ID: 31060735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.
    Zhang H; Wang W; Cheng Y; Song Y; Zhu K; Dang C
    World J Surg Oncol; 2013 Jul; 11():155. PubMed ID: 23849250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
    Jiang DM; Suzuki C; Espin-Garcia O; Lim CH; Ma LX; Sun P; Sim HW; Natori A; Chan BA; Moignard S; Chen EX; Liu G; Swallow CJ; Darling GE; Wong R; Jang RW; Elimova E
    Cancer Med; 2020 May; 9(9):3023-3032. PubMed ID: 32130793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran.
    Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F
    J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma.
    Sudarshan M; Alcindor T; Ades S; Aloraini A; van Huyse M; Asselah J; David M; Frechette D; Brisson S; Thirlwell M; Ferri L
    Ann Surg Oncol; 2015 Jan; 22(1):324-30. PubMed ID: 25023544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan.
    Nakamura T; Ide H; Eguchi R; Ota M; Shimizu S; Isono K
    Dis Esophagus; 2002; 15(3):219-25. PubMed ID: 12444994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas.
    Whitson BA; Groth SS; Li Z; Kratzke RA; Maddaus MA
    J Thorac Cardiovasc Surg; 2010 Jan; 139(1):43-8. PubMed ID: 19660401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma.
    Fields RC; Strong VE; Gönen M; Goodman KA; Rizk NP; Kelsen DP; Ilson DH; Tang LH; Brennan MF; Coit DG; Shah MA
    Br J Cancer; 2011 Jun; 104(12):1840-7. PubMed ID: 21610705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the Esophagogastric Junction in China according to Siewert's classification.
    Bai JG; Lv Y; Dang CX
    Jpn J Clin Oncol; 2006 Jun; 36(6):364-7. PubMed ID: 16766566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for Esophageal Adenocarcinoma.
    Lam KO; Kwong DLW
    Methods Mol Biol; 2018; 1756():19-34. PubMed ID: 29600357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction.
    Marsman WA; Tytgat GN; ten Kate FJ; van Lanschot JJ
    J Surg Oncol; 2005 Dec; 92(3):160-8. PubMed ID: 16299781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
    Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
    BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study.
    Xu H; Zhang L; Miao J; Liu S; Liu H; Jia T; Zhang Q
    World J Surg Oncol; 2020 Jun; 18(1):144. PubMed ID: 32593312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.